ARCHIVES

FDA Advisors Debate Ban, Black Box And Status Quo of Power Morcellators

This article is from The Cancer Letter archive.

Vol. 40 No. 30 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Final stats On FY92 Budget; Success Rate Was 35 Percent

December 4, 1992

NCI Plans Research To Reduce Cancer Disparities.

June 16, 2000

ASCO, Komen Begin Initiative To Address Cancer Care Disparities.

October 31, 2008

As For-Profits Provide Phase I Studies, NCI Seeks to Look Deeper and Learn More

April 6, 2012

In Congress: Human Genome Project Ahead Of Schedule, Collins Assert

March 27, 1998

FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer

September 24, 1999